| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447423 | European Journal of Cancer | 2011 | 10 Pages |
Abstract
The percentage of CD44+CD24lo CSC in the BM is higher in PBC patients with high risk tumour features. The selection or enrichment of Aldefluor+ epithelial cells by NACT may represent an opportunity to target these cells with novel therapies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
James M. Reuben, Bang-Ning Lee, Hui Gao, Evan N. Cohen, Michel Mego, Antonio Giordano, Xuemei Wang, Ashutosh Lodhi, Savitri Krishnamurthy, Gabriel N. Hortobagyi, Massimo Cristofanilli, Anthony Lucci, Wendy A. Woodward,